Furthermore, amplification and overexpression of the negative regulators of p53, mouse double minute 2 (MDM2) and murine double minute X (MDMX), have been observed in 40%–60% of melanoma cases, suggesting functional suppression of p53 in these tumors [15,18]. The gene discussed is TP53; the disease is melanoma.